Spots Global Cancer Trial Database for Axitinib as Maintenance Treatment in Patients With Metastatic CRC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Axitinib as Maintenance Treatment in Patients With Metastatic CRC
Official Title: A Phase II Study of Axitinib as Maintenance Treatment for Patients With Metastatic Colorectal Carcinoma
Study ID: NCT01483638
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the maintenance therapy with axitinib in patients with metastatic colorectal carcinoma
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Spanish Cooperative Group for Digestive Tumour Therapy, Madrid, , Spain
Contact Details
Name: Cristina Grávalos, MD
Affiliation: Hospital 12 de Octubre
Role: STUDY_CHAIR
Name: Alfredo Carrato, MD, PhD
Affiliation: Hospital Universitario Ramon y Cajal
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
